Press Release

Immunodiagnostics Market 2019 Industry Size, Competitive Landscape and Key Regions 2026

Immunodiagnostics Market 2019: Emerging Technologies, Sales Revenue, Key Players Analysis and Industry Expansion Strategies 2026

The increasing number of geriatric population, and occurrences of infectious diseases like cancer, and hepatitis is expected to boost the global immunodiagnostics market. According to a report published by Fortune Business Insights, titled “Immunodiagnostics: Global Market Analysis, Insights, and Forecast, 2018-2025,” the market was valued at US$ 15,777.5 Mn in 2017. Fortune Business Insights predicts that the market will rise at a CAGR of 4.7%, and reach US$ 22,732.7 Mn by the end of 2025.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444

Key players leading the Global Immunodiagnostics Market include

  • Abbott
  • Hoffmann-La Roche AG (Roche Diagnostics)
  • DiaSorin
  • Danaher Corporation
  • QIAGEN
  • bioMérieux
  • Thermo Fisher Scientific
  • Quest Diagnostics.

Abbott, DiaSorin, and Roche Diagnostics are Likely to Hold Significant Share in the Market

Prominent organizations such as Abbott, DiaSorin, and Roche Diagnostics are projected to lead the global immunodiagnostics market during the forecast period. Development strategies, rise in the investments in research and development, cost management, and strong supply chain network are predicted to give impetus to these companies and enable them gain a competitive edge.

Order Full [email protected] https://www.fortunebusinessinsights.com/checkout-page/100444

Asia Pacific to Remain Dominant in the Market

The global immunodiagnostics market can be geographically segmented into Latin America, North America, Asia Pacific, Middle East, Europe and Africa. Amongst these regions, the Asia Pacific market was worth US$ 3,949.1 Mn in 2017, and it is still likely to generate a comparatively high CAGR during the forecast period. As there is an increasing awareness among the masses regarding disease management, it encourages them to go for regular health check-ups and tests. This has also enhanced the global immunodiagnostics market.

Moreover, an increasing number of players in the region, rising awareness, and advancements in health care industry will drive the market in Asia Pacific. It is anticipated that China and India will exhibit high demand for immunodiagnostics in Asia Pacific.  This is because of the presence of unmet medical needs in the region. The immunodiagnostics market in the Middle East and Latin America is projected to expand considerably by the end of 2025, because of the rise in infectious and cardiovascular diseases in these regions.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/immunodiagnostics-market-100444

The immune system of a human is one of the most complex networks. Recent advancements in global immunodiagnostics market have improvised diagnosis of this complex network. A rise in infectious diseases like HIV, cancer, hepatitis, and other cardiovascular diseases is aiding expansion of the immunodiagnostics market. Furthermore, advancements in technology will stoke growth of the global immunodiagnostics market during the forecast period. The report provides an in-depth analysis of various factors that have contributed to the growth of the global immunodiagnostics market.

Oncology and Endocrinology Segment Will Witness Increasing Demand

The immunodiagnostic market is categorized into oncology and endocrinology, infectious disease testing, hepatitis and retrovirus testing, and GI stool testing in terms of application. In 2017, oncology, and endocrinology segment had generated a market share of 25.6%. The segment’s highest share is accredited to the embracing of immunodiagnostics in various applications, namely endocrine diseases and cancer. There has been an increase in the number of reimbursement of products as well as new product approvals. Also, several tests are predicted to propel the global immunodiagnostics market by the end of 2025.

Segmentation

By Product

  • Instruments
  • Reagents & Consumables

By Application

  • Oncology & Endocrinology
  • Hepatitis & Retrovirus
  • Cardiac Markers
  • Infectious Diseases
  • Others

By End user

  • Clinical Laboratories
  • Hospitals
  • Physician’s Offices
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Immunodiagnostic Market to Reach US$ 22,732.7 Mn by 2025, Technological Advancements in Diagnostic Kits to Propel Growth Rate, says Fortune Business Insights

Antithrombin Market to reach US$ 725.2 Mn by 2026, exhibiting a CAGR of 4.1%. | Fortune Business Insights

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close